SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.
|
|
|
|
|
11-50 employees
View all SpliceBio employees
|
|
|
Biotechnology Research
|
|
|
$1M–$5M
|
|
|
(415) 123-4567
|
|
|
Baldiri Reixac 10-12, Parc Cientific de Barcelona, Barcelona, Barcelona 08028, ES
|
|
|
None
|
Neus Carne is the CEO of SpliceBio. To contact Neus Carne email at [email protected].
SpliceBio headquarters is located at Baldiri Reixac 10-12, Parc Cientific de Barcelona, Barcelona, Barcelona 08028, ES.
SpliceBio generates an estimated $1M–$5M annually, based on industry analysis and publicly available market data.
You can contact SpliceBio by calling (415) 123-4567.
SpliceBio headquarters is located at Baldiri Reixac 10-12, Parc Cientific de Barcelona, Barcelona, Barcelona 08028, ES.
SpliceBio generates an estimated $1M–$5M annually, based on industry analysis and publicly available market data.
You can contact SpliceBio by calling (415) 123-4567.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.